An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (GI/GU bleeding management in AF patients using dab)

21/11/2013
30/03/2024
EU PAS number:
EUPAS5214
Study
Finalised
Documents
Study protocol
Study results
Study results
English (129.47 KB - PDF) View document
Study report
Other information